Clinical Trials Browser

Withdrawn × Interventional × loncastuximab tesirine × Clear all

NCT05222438 2023-11-01

Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant

Phase 2 Withdrawn

Lymphoma, Large B-Cell, Diffuse

NCT05228249 2023-01-13

Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma

Phase 1 Withdrawn

Lymphoma, Large B-Cell, Diffuse

NCT04974996 2022-03-29

LOTIS-8

Phase 1 Withdrawn

Lymphoma, Large B-Cell, Diffuse